{{Rsnum
|rsid=5030865
|Gene=CYP2D6
|Chromosome=22
|position=42525035
|Orientation=plus
|ReferenceAllele=G
|GMAF=0.0009183
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
[[rs5030865]] is a SNP in the [[CYP2D6]] gene which defines two inactive variants, CYP2D6*8 and CYP2D6*14. This SNP has changed orientation in different reference genome builds and also has more than two allele changes possible, so references to it can be very confusing. The below are in genome build 37.1 plus orientation, while the "also knowns" are in minus orientation:

[[rs5030865]](C) is the normal variant<br>
[[rs5030865]](A) is the CYP2D6*8 inactive variant, also known as 1758G>T or G169X<br>
[[rs5030865]](T) is the CYP2D6*14 inactive variant, also known as 1758G>A or G169R

{{omim
|id=124030
|rsnum=5030865
|variant=0004
}}

{{ClinVar
|rsid=5030865
|Reversed=0
|FwdREF=C
|FwdALT=A,T
|REF=C
|ALT=A,T
|RSPOS=42525035
|CHROM=22
|GMAF=0.0009
|dbSNPBuildID=113
|SSR=0
|SAO=1
|VP=0x050168000000040516110100
|GENEINFO=CYP2D6:1565
|GENE_NAME=CYP2D6
|GENE_ID=1565
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000022.10:g.42525035C>A
|CLNSRC=GTR; OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=GTR000500503; 124030.0004
|CLNSIG=5
|CLNCUI=C1837156
|CLNDBN=Debrisoquine, poor metabolism of
|Disease=Debrisoquine
|CLNACC=RCV000018388.26
|Tags=PM;PMC;SLO;VLD;HD;GNO;KGPhase1;KGPROD;OTHERKG;LSD;OM
|CAF=0.9991; 0.0009183
|CLNDSDB=MedGen
|CLNDSDBID=C1837156
|COMMON=0
}}

{{PMID Auto
|PMID=18547414
|Title=Genotyping panel for assessing response to cancer chemotherapy.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}